State-of-the-art Manufacturing Facility
In order to control all aspects of Midatech’s GNP platform and its development, the company established a state-of-the-art manufacturing facility near Bilbao, Spain. This cGMP site has sufficient capacity for manufacturing clinical trial materials. The process is engineered to be easily scalable and so capacity can be expanded quickly if needed for larger trials and potential subsequent sales.
Manufacture of sterile injectables for human studies
Midatech has also integrated a separate sterile production unit within its GMP manufacturing facility. Once completed accreditation by the relevant regulatory bodies will be sought. This unit produces candidate GNP-based cancer vaccines and GNP-chemotherapeutics, which are administered by intravenous injection, under sterile conditions for clinical testing.
Home of Bilbao Manufacturing Facility